Testing and General Policies
For Spring Semester 2022
(Updated January 21, 2022)
All students should test again this week in the Myrin Library on Thursday and Friday, January 20-21, during the following timeslots based on last names:
- A through Cas: Thursday between 9 a.m. and 11 a.m.
- Cau through Dum: Thursday between 11 a.m. and 1 p.m.
- Dun through Har: Thursday between 1 p.m. and 3 p.m.
- Has through Lee: Thursday between 3 p.m. and 5 p.m.
- Lef through Mue: Friday between 9 a.m. and 11 a.m.
- Muh through Rob: Friday between 11 a.m. and 1 p.m.
- Roc through Tan: Friday between 1 p.m. and 3 p.m.
- Tat through Z: Friday between 3 p.m. and 5 p.m.
Please arrive as close as possible to your timeslot.
We have updated the dashboard with this week’s on-campus testing results, and we will continue to provide a Friday morning Instagram post that clearly states transmission rate among campus. Our initial round of arrival testing on Tuesday and Wednesday had a positivity rate of just below 2%–slightly better than our expectations and a percentage for which we have been preparing.
As of Friday morning, January 21, in our second round of all-student tests, we are seeing a positivity rate below 1%. Every student must test again once next week, which will continue to closely monitor the health of campus as we begin our semester.
Quarantine/ Isolation Guidance
(Updated January 19, 2022)
Ursinus is adopting, with minor modifications, the recently revised guidance from the CDC on quarantine and isolation. These changes reflect the more rapid progression of disease from the Omicron variant, as well as a desire to reduce disruption from long periods of separation.
Isolation refers to steps taken for individuals who test positive, or otherwise are assumed to have contracted COVID.
- All infected individuals should remain isolated for 5 full days the date of the positive test. For students who live within driving distance of campus, the assumption is that they will do isolate at home, as the college has very limited space for isolation.
- On or after the sixth day, those with either mild or no symptoms (without fever) who test negative may re-enter usual activities. They should avoid large groups and wearing a KN95 mask for the following five days. We ask that these individuals also come to the testing site on the first available day for antigen testing to monitor their recovery; they should identify themselves to the testing personnel as returning from isolation.
- Those who continue to test positive should remain in isolation for a full ten days. Those who experience serious symptoms, should consult with Wellness or their family physician. They may return to regular activities at that point if symptoms have largely disappeared and they have been without fever for at least 24 hours.
Close contacts of positive cases, as identified by our Contact Tracing team, should also follow certain precautions, depending on their vaccination status.
- For those whose vaccination status is not up-to-date*, they must quarantine for a five-day period following their last exposure. Students who live within driving distance of campus are expected to quarantine at home; all students who are unvaccinated must have a quarantine and isolation plan. At the five-day point, these individuals should get a COVID test, and if negative, may return to regular activities with extra precautions for the next five days: consistent mask wearing, avoiding those in high-risk groups, testing daily whenever the testing site is open for the next five days, and watching for symptoms.
- For those whose vaccination is up-to-date*, contacts may continue usual activities with extra precautions for a ten-day period: consistent mask wearing, avoiding high risk groups, testing daily whenever the testing site is open for a full week following exposure, being alert for symptoms.
*Up-to-date is defined by the CDC to include individuals who are both 1) fully vaccinated (two weeks past final dose of an EUA approved vaccine) and 2) boosted if they are eligible. Booster eligibility currently begins five months past the second dose of Moderna or Pfizer vaccines, or two months past the administration of the J&J vaccine.